Henry Schein today announced it signed an agreement to acquire Acentus, a national supplier of home care medical products.
The Acentus transaction follows Henry Schein’s acquisition of Shield Healthcare in 2023 and Prism Medical Products in 2021. Financial terms of the latest deal were not disclosed.
“As the delivery of health care in the U.S. is increasingly provided in home-based settings, Henry Schein is strategically expanding our offerings to meet the growing demand,” CEO Stanley Bergman said in a news release. “We are pleased to announce our acquisition of Acentus, which enhances our ability to deliver CGM products directly to patients’ homes. With Acentus, we will strengthen our position nationally in the home medical supply market and better serve our valued customers, including clinics, physician practices, health systems, ambulatory surgery centers, and most importantly, patients and families.”
Henry Schein’s home care medical products platform is now expected to have an annual revenue base of approximately $350 million.
Acentus, headquartered in Tampa, Florida, has an annual revenue of approximately $35 million. Closing of the deal is subject to standard closing conditions. It is expected to close in the first quarter of 2025.
“We are delighted to partner with Henry Schein and further our efforts to provide accessible disposable medical supplies to the thousands of individuals nationwide who rely on these products to manage their chronic conditions,” said Acentus CEO Todd Clanfrocca.
Upon the acquisition’s closing, founders Brett Carroll, Todd Clanfrocca, Greg Duvall and Julio Valdivia will join Henry Schein.
